Discover IMRX’s innovative cancer drug atebimetinib and upcoming milestones. Learn about trial results, financial outlook, ...

The past year has been a continuation of an unceasing tech rally, one that may continue well into 2026 and beyond. If you are ...

Ultragenyx Pharmaceutical (RARE) remains a Sell after its Phase 3 OI program failed to meet primary fracture reduction ...

By Jonathan Joel Mentor  The Dominican Republic doesn’t have one economy. It has two. One sits on this side of the water: ...

UPrinting reports 25% of business owners lost clients to AI tools, raising concerns over authenticity. Many seek balance, ...

Knowable Magazine reports 2025 faced turmoil in U.S. science amid job cuts and budget slashes, yet saw advances in gene ...

We celebrate the incredible achievements of all those pioneering scientists, straight-talking campaigners and brilliant ...

The tax would likely have an outsized effect on the Bay Area's richest, the Chronicle's analysis indicated. The bulk of ...

For decades, white-collar workers were told that a degree and a desk would buy them stability. That bargain is unraveling ...

While society obsesses over IQ scores and academic achievements, the most intelligent people are quietly displaying subtle ...

A drug once designed for dengue virus, then quietly abandoned by industry, is suddenly back in the spotlight, and it may be ...

And while most eyes were on the US in 2025, one consequence of the Trump administration’s new national security strategy could be that other countries – particularly in the eastern hemisphere – now ...